11 Patents
- 0 cites
- US125707102026Targeting LILRB4 with CAR-T or CAR-NK Cells in the Treatment of Cancer
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites - US125035002025Connexin 43 (cx43) Hemichannel-binding Antibodies
Board Of Regents, The University Of Texas System
0 cites - US123311102025Monoclonal Antibodies Against Endotrophin and the Use Thereof
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites - 0 cites
- 0 cites
- US121520712024EGFL6 Specific Monoclonal Antibodies and Methods of Their Use
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites - US120373902024Leptin Antibodies and Method of Reducing Leptin
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
0 cites - US119127582024Methods of Treating Metastasis, Including Inhibiting Bone Cancer Metastasis, by Administering an Antibody Which Binds Connexin 43 (cx43) Hemichannel
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites - US119065192024Methods for Identifying Lilrb-blocking Antibodies
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
0 cites - 0 cites